Ligand Board Authorizes Reverse Stock Split and $10 Million Share Repurchase
Ligand to Present at the Jefferies Global Life Sciences Conference on June 9
Ligand Acquired Milestone and Royalty Interest in AstraZeneca IL-9 Program for Asthma
Ligand to Present at the MDB Capital Group Bright Lights Conference on May 11
Ligand Pharmaceuticals Announces First Quarter Results
Ligand to Report First Quarter Results on May 5th
Ligand Earns $6.5 Million Milestone Payment from Roche
Ligand Presents First-in-Human Phase I Data on Lead SARM Molecule LGD-4033 at the International Congress of Endocrinology
Ligand Announces Approval for Revolade(R) in Europe
Ligand to Present at the Cowen & Company 30th Annual Healthcare Conference on March 11
Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Results
Ligand to Report Fourth Quarter Results on February 9th
Ligand Completes Acquisition of Metabasis
Ligand Earns $1 Million in Milestone Payment from Merck & Co., Inc.
